Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.
Ann Intern Med. 2022 Nov;175(11):1506-1514. doi: 10.7326/M22-0318. Epub 2022 Oct 18.
Ann Intern Med. 2022.
PMID: 36252244
Free PMC article.
Clinical Trial.
Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease.
Dawwas GK, Barnes GD.
Dawwas GK, et al.
Curr Cardiol Rep. 2022 Jun;24(6):731-738. doi: 10.1007/s11886-022-01690-9. Epub 2022 Apr 23.
Curr Cardiol Rep. 2022.
PMID: 35460473
Free PMC article.
Review.
Item in Clipboard
Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.
Dawwas GK, Flory JH, Hennessy S, Leonard CE, Lewis JD.
Dawwas GK, et al.
Diabetes Care. 2022 Apr 1;45(4):919-927. doi: 10.2337/dc21-2177.
Diabetes Care. 2022.
PMID: 35147696
Free PMC article.
Item in Clipboard
Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population-based analysis in response to CVS 2022 formulary changes.
Dawwas GK, Cuker A, Connors JM, Barnes GD.
Dawwas GK, et al.
Am J Hematol. 2022 May;97(5):E173-E176. doi: 10.1002/ajh.26494. Epub 2022 Feb 24.
Am J Hematol. 2022.
PMID: 35147235
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite